Dr. Silvia Fossati receives the Scott Richards North Star Foundation and Stop Alzheimer’s Now Endowed Chair at Temple University

15 October 2026

New Publication

Nicole Lemon published a peer-reviewed article in the journal Science Advances, Oct 2026

“Mitochondrial carbonic anhydrase–VB inhibition rescues brain endothelial stress and memory in Alzheimer’s disease models”

Top Downloaded Article

Silvia Fossati’s paper;

“Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers”

was one of the most downloaded during its first 12 months of publication in: ALZHEIMER'S & DEMENTIA

Among work published in an issue between 1 January 2022 – 31 December 2022

AAIC 2026 Conference

Fossati Lab participated in the AAIC 2026 conference, London, UK ‍

Washington Post Article, Interview with Dr Fossati, October 30, 2024

“ Want to cut your dementia risk? Keep your blood pressure in check.”

Publication

Ashley Carey published a peer-reviewed article in the journal of Aging Cell, Feb 2024

“Homocysteine potentiates amyloid β-induced death receptor 4- and 5-mediated cerebral endothelial cell apoptosis, blood-brain barrier dysfunction and angiogenic impairment”

Publication

Amy Anzovino published a peer-reviewed article in the journal of Cells, Dec 2023

“Amyloid Beta Oligomers Activate Death Receptors and Mitochondria-Mediated Apoptotic Pathways in Cerebral Vascular Smooth Muscle Cells; Protective Effects of Carbonic Anhydrase Inhibitors

Publication

Elisa Canepa published a peer-reviewed article in the Journal of Alzheimer’s & Dementia, Apr 2023

“FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness”